Ms. Sumeray et al., BEYOND COAGULATION - FIBRINOGEN AS A CAUSE OF CARDIOVASCULAR SURGICALDISEASE, Cardiovascular drugs and therapy, 12(3), 1998, pp. 261-265
Citations number
50
Categorie Soggetti
Pharmacology & Pharmacy","Cardiac & Cardiovascular System
Fibrinogen is generally considered to be an important mediator of clot
formation. However, its effects on clots and perhaps other more direc
t effects may also make it a powerful mediator in the genesis and prog
ression of atheromatous disease. Indeed, raised fibrinogen levels may
pose as great a cardiovascular risk as classical risk factors such as
elevated blood pressure or cholesterol levels. The plasma fibrinogen l
evel of any given individual, and its associated cardiovascular risk,
is dependent upon an interaction between environmental and intrinsic (
genetic) factors. Most environmental factors associated with elevated
fibrinogen levels are also potent cardiovascular risk factors (e.g., c
igarette smoking). Less is known of the role played by genetic factors
. However, as research into the genotypic influences on both basal and
''stimulated'' fibrinogen production continues, high-risk groups may
be identified that may benefit hom therapeutic intervention aimed at l
owering plasma fibrinogen.